IMYOO

imyoo-logo

ImYoo Inc., a direct-to-consumer single-cell transcriptomics company from the California Institute of Technology, aims to deliver personalized, biology-driven health insights by connecting people with similar immune profiles to share their health journeys.

#People #Financial #Website #More

IMYOO

Social Links:

Industry:
Biotechnology

Founded:
2021-07-09

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.imyoo.health

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business Google GStatic Google Static Content Google Cloud


Current Employees Featured

david-brown_image

David Brown
David Brown CTO/Co-founder @ ImYoo
CTO/Co-founder

tatyana-dobreva_image

Tatyana Dobreva
Tatyana Dobreva CEO @ ImYoo
CEO

Founder


david-brown_image

David Brown

tatyana-dobreva_image

Tatyana Dobreva

Investors List

illumina-accelerator_image

Illumina Accelerator

Illumina Accelerator investment in Seed Round - ImYoo

Official Site Inspections

http://www.imyoo.health

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "ImYoo"

ImYoo - LinkedIn

ImYoo | 756 followers on LinkedIn. ImYoo is a biodiscovery platform which puts patients at the center by combining at-home blood collection and multiomics | ImYoo is debugging the human โ€ฆSee details»

ImYoo 2025 Company Profile: Valuation, Funding

Information on valuation, funding, cap tables, investors, and executives for ImYoo. Use the PitchBook Platform to explore the full profile.See details»

MDSS - ImYoo

ImYoo is a patient-enabled biodiscovery platform, providing end-to-end data generation and data access to therapeutics companies and academic partners. From a small at-home blood โ€ฆSee details»

ImYoo - Crunchbase Company Profile & Funding

ImYoo is a biodiscovery platform which puts patients at the center by combining at-home blood collection and multiomicsSee details»

ImYoo - VentureRadar

Provides a patient-centered biodiscovery platform using multi-omic tools for precision diagnosis and therapy, enabling real-time health event data collection and disease understanding. โ€ฆSee details»

ImYoo | Patient-driven Biodiscovery

ImYoo is a biotech startup debugging the human immune system. By coupling at-home blood collection and single-cell RNA sequencing, we enable high resolution insights across time.See details»

How ImYoo is decentralizing immune profiling at โ€ฆ

This whitepaper describes ImYoo's end-to-end platform which integrates YourBio Healthโ€™s TAP II virtually painless at-home blood collection device, multiplexed single-cell RNA sequencing, and automated data analysis. With this platform โ€ฆSee details»

ImYoo - GitHub

ImYoo aims to connect people with similar cellular-level immune profiles to share their health journey and interventions - ImYooSee details»

ImYoo - MarsBio

ImYoo captures immune variability within individuals using single-cell gene expression profiling methods, which can be used to obtain the gene expression levels of thousands of genes in โ€ฆSee details»

ImYoo | Jumpcode Genomics

ImYoo is a single-cell transcriptomics startup that helps biopharma companies stratify study participants to optimize clinical trials. The company is also building a direct-to-consumer business to deliver personalized, evidence-driven health โ€ฆSee details»

Patients | ImYoo

ImYoo pairs your self-knowledge with researchers who have complementary expertise in disease biology and the latest scientific techniques. Your contributions as a patient scientist can help โ€ฆSee details»

Contact | ImYoo - imyoo.health

Talk to Imyoo To meet the varied needs of our partners, there are two main routes to work with us. First, you can tap into our rich database of single cell transcriptomics data to uncover novel โ€ฆSee details»

Researchers | ImYoo

ImYoo's technology is an end-to-end workflow for collecting, processing, and analyzing PBMCs collected from whole blood for single-cell RNA sequencing. The platform also includes an โ€ฆSee details»

FAQ | ImYoo

ImYoo is leveraging YourBio Health's capillary blood self-collection device called TAP II. With a gentle adhesive, the device sticks to your arm. After you press down on the plunger, the โ€ฆSee details»

Blog | ImYoo - imyoo.health

Next Steps The results of this RemissionBiome-ImYoo collaboration have seeded hope for a new way of doing research. After completing this N of 1 study, Falor founded RenegadeResearch, โ€ฆSee details»

Home - Woodbridge Medical Centre Family Health Team

The Woodbridge Medical Centre Family Health Team (WMC FHT) is a collaborative primary health care team composed of a Dietitian, Family Physicians, Family Practice Nurses, Nurse โ€ฆSee details»

World Health Organization - Wikipedia

The World Health Organization (WHO) is a specialized agency of the United Nations which coordinates responses to international public health issues and emergencies. [2] It is โ€ฆSee details»

Home | Youth Wellness Hubs Ontario

At the hubs, youth can access mental health and substance use services, primary health care, peer support, education and employment services, and additional resources to support skill โ€ฆSee details»

PWCCF - Empowering through philanthropy

Our mission is to create a stronger, healthier, and more connected community by addressing critical needs in food insecurity, health & wellness, scholarship, and philanthropy. We are โ€ฆSee details»

How the World Health Organizationโ€™s โ€˜One Healthโ€™ framework can โ€ฆ

Aug 14, 2025 The WHOโ€™s One Health framework links human, animal and environmental health but suffers from slow, fragmented policy delivery. Economist and academic Mariana โ€ฆSee details»

linkstock.net © 2022. All rights reserved